CSE: PHRMOTCQB: PHRRF

Pharmaceutical 3D printing for medicines.

Powered by

Cutaway render of the CORR3CT colon-targeted pill-in-pill tabletRender of a two-layer mucoadhesive oral film on the cheek liningCraftMake Production Plus pharmaceutical 3D printer from Craft Health

Two delivery platforms

We 3D-print medicines at room temperature, with no heat and no UV, on two delivery platforms. Our initial pipeline is peptides, which usually must be injected: under 1% of a swallowed dose is absorbed. Since October 2026, HHS lets 503A pharmacies compound six peptides; only KPV and BPC-157 are covered for oral use.

Cutaway render of the CORR3CT pill-in-pill tablet showing the inner pill inside the enteric shell

Colon-targeted

The patent-pending pill-in-pill holds through the stomach and releases its dose in the colon, where gut disease is.

SwallowedReleased in the colon
Render of a two-layer mucoadhesive oral film on the cheek lining

Mucoadhesive Oral films

A printed mucoadhesive film sticks to the inside of the cheek. The dose passes through the cheek lining into the bloodstream, bypassing the gut and first-pass liver metabolism.

Placed on the inner cheekSystemic delivery

Initial pipeline: BPC-157 and KPV

Both peptides are being developed on both platforms.

Explore our peptide pipeline

Compounded products are patient-specific prescriptions and are not FDA-approved. No efficacy claims are made. The oral film is in development and its regulatory pathway has not been established. Images are renders.